Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) NASDAQ

26.04

+0.011(+0.04%)

Updated at September 30 01:29PM

Currency In USD

General
Statistics
Historical Data
Profile
Financials

Harrow Health, Inc. 11.875% Senior Notes due 2027

Address

Nashville,

United States of America

Phone

N/A

Website

http://www.harrowinc.com

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

217

First IPO Date

December 29, 2022

Key Executives

N/A

Description

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.